Chiesi has launched Envarsus, the first prolonged-release...
The once-daily basal insulin analogue Tresiba (insulin...
Celgene has launched Otezla (apremilast) for use in...
Remsima and Inflectra are the first biosimilar monoclonal...
NICE has broadened its guidance on the use of TNF-inhibiting...
New and deleted products
Quick-reference guide to switching and withdrawing...
Summary of NICE guidance for treatment of Helicobacter...
Dose regimens for common bacterial infections.
Quick-reference table for comparison of insulin profiles.
Guide to strengths and preparations of topical steroids
Featured MIMS resources
Formulation, strength and dose information for oral iron supplements used in iron-deficiency states.
A quick reference guide to the primary and secondary prevention of cardiovascular disease
New products coming soon to MIMS
Check back soon to find MIMS listings for the following new drugs:
Hyabak UD (sodium hyaluronate)
Orphacol (cholic acid)
Zevtera (ceftobiprole medocaril sodium)
The hyperpigmentation disorder melasma can be distressing...
Patients with moderate to severe psoriasis are at increased...
A US study investigated whether having podiatry before...
Prescribing news and resources for key therapeutic areas, collated by the MIMS editors.
Register for MIMS
Want to keep getting your free copy of MIMS? GPs will need to renew their subscription to keep receiving MIMS and GP for free in 2015. You can do this online now – take 2 minutes, and make sure you keep your free MIMS access!
News and updates straight to your inbox.
Prescribing Update: Fortnightly news bulletin
Spotlight: Disease-themed monthly round-up
Read the latest issue online exclusively on MIMS.
Handy calculators and conversions for primary care.